| 1 | 1-(6-甲基-3-吡啶)-2-[4-(甲巯基)苯基]-乙酮 | 1-(6-Methylpyridin-3-yl)-2-[4-(methylthio)phenyl]ethanone | 221615-72-1 | 中间体-医药中间体 | |
| 2 | 1-(6-甲基吡啶-3-基)-2-[4-(甲基磺酰基)苯基]乙酮 | 1-(6-methyl-3-pyridyl)-2-[4-(methylsulfonyl)-phenyl]ethanone | 221615-75-4 | 中间体- | |
| 3 | 6-甲基烟酸甲酯 | Methyl 6-methylnicotinate | 5470-70-2 | 中间体- | |
| 4 | 2-氯-1,3-双(二甲基氨基)三亚甲六氟磷酸盐 | 2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate | 249561-98-6 | 中间体- | |
| 5 | 2,3-二甲基-6-氨基-2H-吲唑盐酸盐 | 2,3-Dimethyl-2H-indazol-6-amine hydrochloride | 635702-60-2 | 中间体- | |
| 6 | 盐酸帕唑帕尼 | Pazopanib hydrochloride(API) | 635702-64-6 | 中间体- | |
| 7 | 帕唑帕尼游离碱 | Pazopanib Free Base | 444731-52-6 | 中间体- | |
| 8 | 5-氯-2-羟基-[1,1-联苯]-3-羧酸 | 5'-chloro-2'-hydroxy-[1,1'-Biphenyl]-3-carboxylic acid | 376592-57-3 | 中间体-医药中间体 | |
| 9 | 5'-氯-3'-硝基-2'-羟基-[1,1'-联苯]-3-甲酸 | 5'-chloro-2'-hydroxy-3'-nitro-[1,1'-Biphenyl]-3-carboxylic acid | 376592-58-4 | 中间体- | |
| 10 | 3'-氨基-2'-羟基-[1,1'-联苯]-3-甲酸 | 3'-amino-2'-hydroxybiphenyl-3-carboxylic acid | 376592-93-7 | 中间体- | |
| 11 | 3'-氨基-2'-羟基-[1,1'-联苯]-3-甲酸盐酸盐 | 3'-amino-2'-hydroxybiphenyl-3-carboxylic acid hydrochloride | 376591-97-8 | 中间体-医药中间体 | |
| 12 | 3-甲基-1-(3,4-二甲基苯基)-2-吡唑啉-5-酮、 | 3-Methyl-1-(3,4-dimethylphenyl)-2-pyrazolin-5-one、 | 18048-64-1/ | 中间体-医药中间体 | |
| 13 | 2-(3,4-二甲基苯基)-1,2-二氢-5-甲基-3H-吡唑-3-酮 | 2-(3,4-Dimethylphenyl)-1,2-dihydro-5-methyl-3H-pyrazol-3-one | 277299-70-4 | 中间体- | |
| 14 | 艾曲波帕游离碱 | Eltrombopag Free Base | 496775-61-2 | 中间体- | |
| 15 | 艾曲波帕乙醇胺 | Eltrombopag Olamine (API) | 496775-62-3 | 中间体- | |
| 16 | 3'-硝基-2'-羟基联苯-3-羧酸 | 2'-Hydroxy-3'-nitro-[1,1'-biphenyl]-3-carboxylic acid | 376591-95-6 | 中间体- | |
| 17 | 2-[2-(6-溴己氧基)乙氧基甲基]-1,3-二氯苯 | 2-[2-(6-BroMohexyloxy)ethoxyMethyl]-1,3-dichlorobenzene | 503070-57-3 | 中间体-医药中间体 | |
| 18 | 2-恶唑烷酮, 5-(2,2-二甲基-4H-1,3-苯并二氧-6-YL), (5R)- | 2-Oxazolidinone, 5-(2,2-diMethyl-4H-1,3-benzodioxin-6-yl)-, (5R)- | 452339-73-0 | 中间体-医药中间体 | |
| 19 | 维兰特罗三苯乙酸盐 | Vilanterol Trifenatate (API) | 503070-58-4 | 中间体- | |
| 20 | 3-环丙基-1-(2-氟-4-碘苯基)-6-甲基氨基-1H-嘧啶-2,4-二酮 | 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6-(methylamino)pyrimidine-2,4(1H,3H)-dione | 871700-22-0 | 中间体-医药中间体 | |
| 21 | 3-环丙基-1-(2-氟-4-碘苯基)-5-羟基-6,8-二甲基-1H,8H-吡啶并[2,3-D]嘧啶-2,4,7-三酮 | 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione | 871700-24-2 | 中间体-医药中间体 | |
| 22 | 曲美替尼二甲亚砜 | TraMetinib DMSO (API) | 1187431-43-1 | 中间体-医药中间体 | |
| 23 | 曲美替尼游离碱 | Trametinib free base | 871700-17-3 | 中间体- | |
| 24 | 2-氟-3-胺基苯甲醚 | Methyl 3-amino-2-fluorobenzoate | 1195768-18-3 | 中间体- | |
| 25 | 3-[[(2,6-二氟苯基)磺酰基]氨基]-2-氟苯甲酸甲酯 | Methyl 3-{[(2,6-difluoropheyl)sulfonyl]amino}-2-fluorabenzoate | 1195768-19-4 | 中间体-医药中间体 | |
| 26 | 2,2,2-三甲基硫代乙酰胺 | 2,2,2-Trimethylthioacetamide | 630-22-8 | 中间体- | |
| 27 | 达拉芬尼游离碱 | Debrafenib free base | 1195765-45-7 | 中间体-医药中间体 | |
| 28 | 达拉芬尼甲磺酸盐 | Dabrafenib Mesylate (API) | 1195768-06-9 | 中间体-医药中间体 | |
| 29 | 1-(2,2-二甲氧基乙基)-1,4-二氢-3-甲氧基-4-氧代-2,5-吡啶二甲酸 2-甲酯 | 1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid | 1335210-23-5 | 中间体-医药中间体 | |
| 30 | (4R,12aS)-3,4,6,8,12,12a-六氢-7-甲氧基-4-甲基-6,8-二氧代-2H-吡啶并[1',2':4,5]吡嗪并[2,1-b][1,3]恶嗪-9-羧酸 | (4R,12aS)-7-Methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxylic acid | 1335210-34-8 | 中间体-医药中间体 | |
| 31 | (4R,12aS)-N-((2,4-二氟苯基)甲基)-3,4,6,8,12,12a-六氢-7-甲氧基-4-甲基-6,8-二氧代-2H-吡啶并(1',2':4,5)吡嗪并(2,1-b)(1,3)恶嗪-9-甲酰胺 | (4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide | 1335210-35-9 | 中间体-医药中间体 | |
| 32 | 度鲁特韦 | Dolutegravir | 1051375-16-6 | 中间体- | |
| 33 | 度鲁特韦钠盐 | Dolutegravir Sodium ( API) | 1051375-19-9 | 中间体- | |
| 34 | 4-氧代-3-苄氧基-4H-吡喃-2,5-二甲酸二甲酯 | 4-Oxo-3-(phenylMethoxy)-4H-pyran-2,5-dicarboxylic acid 2,5-diMethyl ester | 1246616-66-9 | 中间体- | |
| 35 | 乙基奎宁环-4-羧酸酯 | Ethyl quinuclidine-4-carboxylate | 22766-68-3 | 中间体-医药中间体 | |
| 36 | 乙基奎宁环-4-羧酸酯盐酸盐 | Ethyl quinuclidine-4-carboxylate hydrochloride | 22766-67-2 | 中间体-医药中间体 | |
| 37 | 苄基2-溴乙基醚 | Benzyl 2-Bromoethyl Ether | 1462-37-9 | 中间体- | |
| 38 | 芜地溴铵原料药 | Umeclidinium bromide(API) | 869113-09-7 | 中间体-医药中间体 | |
| 39 | 5-(2R)-2-环氧乙烷基-8-苄氧基-2(1H)-喹啉酮 | 5-(2R)-2-Oxiranyl-8-benzyloxy-2(1H)-quinolinone | 173140-90-4 | 中间体- | |
| 40 | 茚达特罗马来酸盐(API) | Indacaterol Maleate(API) | 753498-25-8 | 中间体- | |
| 41 | 8-苄氧基-5-(2-溴乙酰基)-1H-喹啉-2-酮 | 8-Benzyloxy-5-(2-bromoacetyl)-2-hydroxyquinoline | 100331-89-3 | 中间体- | |
| 42 | 塞来昔布 | Celecoxib | 169590-42-5 | 中间体- | |
| 43 | 三硫代碳酸二甲酯 | Dimethyl Trithiocarbonate | 2314-48-9 | 中间体-医药中间体 | |
| 44 | 1,5,7-三氮杂二环[4.4.0]癸-5-烯 | 1,5,7-Triazabicyclo[4.4.0]dec-5-ene | 5807-14-7 | 中间体-医药中间体 | |
| 45 | 7-甲基-1,5,7-三氮杂二环[4.4.0]癸-5-烯 | 7-Methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene | 84030-20-6 | 中间体-医药中间体 | |
| 46 | 4-氯-6-氟喹啉 | 4-Chloro-6-fluoroquinoline | 391-77-5 | 中间体- | |
| 47 | 羟乙基淀粉 | Hydroxyethyl starch | 9005-27-0 | 中间体- | |
| 48 | N,N-二十八烷基苯胺 | N,N-dioctadecylaniline | 72072-19-6 | 中间体-医药中间体 | |
| 49 | N-叔丁基-3-氯丙烷-1-磺酰胺 | N-(tert-butyl)-3-chloropropane-1-sulfonamide | 63132-85-4 | 中间体- | |
| 50 | Cyclopropanecarbothioamide | Cyclopropanecarbothioamide | 20295-34-5 | 中间体-医药中间体 | |